To the Editor: Dr Lo and colleagues1 concluded that intra-articular hyaluronan injections
have little benefit for osteoarthritis (OA) of the knee and that the effect
is similar in magnitude to the superiority of nonsteroidal anti-inflammatory
drugs (NSAIDs) over acetaminophen. It is important to recognize that the reported
effect size is small because it is measured over a control that cannot be
considered a simple placebo. Arthrocentesis has been reported to provide symptomatic
relief in patients with a significant effusion.2 Effectiveness
trials are more clinically relevant than efficacy trials, for the former are
more directly related to outcomes of actual practice. In contrast, however,
most trials of intra-articular hyaluronan have been efficacy trials, which
were required for regulatory approval. Thus, it is important to point out
that 2 recent effectiveness trials have found intra-articular hyaluronan injection
to be both clinically beneficial and cost effective.3-5